Ocena wykazu potrzeb regulacyjnych
Ocena wykazu potrzeb regulacyjnych
The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed.
For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.
The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Last updated 23 kwietnia 2024. Database contains 4860 unique substances/entries.
238-878-4
|
14808-60-7
|
Netherlands
|
STOT RE |
Concluded
|
Restriction Other legislation |
10-mar-2023
|
Details | |
629-719-3
|
1219010-04-4
|
Sweden
|
STOT RE |
Concluded
|
None
|
16-kwi-2019
|
Details | |
238-455-4
|
14464-46-1
|
Netherlands
|
STOT RE |
Concluded
|
Restriction Other legislation |
10-mar-2023
|
Details | |
200-843-6
|
75-15-0
|
France
|
STOT RE |
Under development
|
No suggestion yet
|
Details | ||
233-710-6
|
10325-94-7
|
Sweden
|
Carcinogenic Mutagenic STOT RE |
Concluded
|
SVHC
|
09-cze-2017
|
Details | |
208-168-9
|
513-78-0
|
Sweden
|
Carcinogenic Mutagenic STOT RE |
Concluded
|
SVHC
|
09-cze-2017
|
Details | |
696-364-9
|
133779-11-0
|
Sweden
|
STOT RE |
Concluded
|
None
|
16-kwi-2019
|
Details | |
292-562-0
|
90640-43-0
|
Sweden
|
STOT RE |
Concluded
|
None
|
16-kwi-2019
|
Details | |
230-528-9
|
7173-62-8
|
Sweden
|
STOT RE |
Concluded
|
None
|
16-kwi-2019
|
Details | |
show/hide
|
799-976-5
|
-
|
France
|
Endocrine disruption Skin sensitiser |
Concluded
|
SVHC
|
29-kwi-2019
|
Details |
204-112-2
|
115-86-6
|
France
|
Endocrine disruption Skin sensitiser |
Concluded
|
Other
|
10-wrz-2019
|
Details | |
show/hide
|
-
|
-
|
Sweden
|
Skin sensitiser |
Concluded
|
Restriction
|
02-lut-2017
|
Details |
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
show/hide
Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.
EC / List no:
939-460-0
| CAS no:
1471311-26-8
Formaldehyde, reaction products with branched and linear heptylphenol, carbon disulfide and hydrazine
EC / List no:
300-298-5
| CAS no:
93925-00-9
|
-
|
-
|
Austria
|
Endocrine disruption Skin sensitiser |
Concluded
|
SVHC
|
05-lip-2017
|
Details |
611-341-5
|
55965-84-9
|
Netherlands
|
Skin sensitiser |
Concluded
|
Restriction
|
30-lis-2023
|
Details | |
201-607-5
|
85-44-9
|
Portugal
|
Respiratory sensitiser Skin sensitiser |
Under development
|
No suggestion yet
|
Details | ||
276-745-2
|
72629-94-8
|
Germany
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Restriction
|
07-mar-2017
|
Details | |
247-761-7
|
26530-20-1
|
Netherlands
|
Skin sensitiser |
Concluded
|
Restriction
|
30-lis-2023
|
Details | |
204-260-8
|
118-56-9
|
France
|
Endocrine disruption Respiratory sensitiser Skin sensitiser |
Concluded
|
Other
|
27-mar-2019
|
Details | |
212-485-8
|
822-06-0
|
Germany
|
Endocrine disruption Skin sensitiser |
Concluded
|
Restriction
|
23-wrz-2014
|
Details | |
235-921-9
|
13048-33-4
|
Sweden
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
SVHC
|
04-maj-2015
|
Details | |
203-856-5
|
111-30-8
|
Sweden
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
SVHC
|
08-cze-2020
|
Details | |
231-781-8
|
7727-21-1
|
France
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Other legislation
|
02-mar-2020
|
Details | |
231-786-5
|
7727-54-0
|
France
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Other legislation
|
02-mar-2020
|
Details | |
232-565-6
|
9000-90-2
|
United Kingdom
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Other
|
17-lip-2018
|
Details | |
255-288-2
|
41272-40-6
|
Netherlands
|
Skin sensitiser |
Concluded
|
CLH
|
15-gru-2017
|
Details | |
250-863-4
|
31906-04-4
|
Sweden
|
Skin sensitiser |
Concluded
|
Other
|
05-cze-2015
|
Details | |
202-966-0
|
101-68-8
|
Germany
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Restriction
|
19-gru-2016
|
Details | |
225-863-2
|
5124-30-1
|
Germany
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Restriction
|
09-cze-2017
|
Details | |
223-861-6
|
4098-71-9
|
Sweden
|
Exposure Mutagenic Skin sensitiser |
Concluded
|
None
|
09-lut-2018
|
Details | |
247-499-3
|
26172-54-3
|
Netherlands
|
Skin sensitiser |
Concluded
|
Restriction
|
30-lis-2023
|
Details | |
220-239-6
|
2682-20-4
|
Denmark
|
Skin sensitiser |
Concluded
|
Other legislation
|
04-maj-2015
|
Details | |
220-239-6
|
2682-20-4
|
Netherlands
|
Skin sensitiser |
Concluded
|
Restriction
|
30-lis-2023
|
Details | |
203-080-7
|
103-11-7
|
Sweden
|
Skin sensitiser |
Concluded
|
None
|
15-sie-2017
|
Details | |
204-881-4
|
128-37-0
|
France
|
Carcinogenic Endocrine disruption Exposure Skin sensitiser |
Concluded
|
Other legislation
|
28-lut-2017
|
Details | |
219-799-4
|
2536-05-2
|
Germany
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Restriction
|
23-wrz-2014
|
Details | |
220-474-4
|
2778-42-9
|
Germany
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Restriction
|
23-wrz-2014
|
Details | |
220-120-9
|
2634-33-5
|
Netherlands
|
Skin sensitiser |
Concluded
|
Restriction
|
30-lis-2023
|
Details | |
256-032-2
|
42978-66-5
|
Sweden
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
None
|
15-sie-2017
|
Details | |
242-060-2
|
18172-67-3
|
Greece
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
CLH
|
05-lip-2017
|
Details | |
202-112-7
|
91-97-4
|
Germany
|
Respiratory sensitiser |
Concluded
|
Restriction
|
23-wrz-2014
|
Details | |
202-039-0
|
91-08-7
|
Germany
|
Respiratory sensitiser |
Concluded
|
Restriction
|
23-wrz-2014
|
Details | |
show/hide
Triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane
EC / List no:
257-473-3
| CAS no:
51851-37-7
Trimethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane
EC / List no:
288-657-1
| CAS no:
85857-16-5
|
-
|
-
|
Denmark
|
Respiratory sensitiser |
Concluded
|
Restriction
|
06-lut-2015
|
Details |
262-967-7
|
61788-32-7
|
Finland
|
Aggregated tonnage Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
SVHC
|
09-lis-2017
|
Details | |
262-967-7
|
61788-32-7
|
Italy
|
Bioaccumulation Persistence |
Under development
|
No suggestion yet
|
Details | ||
X4261
|
401-850-9
|
255881-94-8
|
Belgium
|
Bioaccumulation Other environmental toxicity Persistence |
Under development
|
No suggestion yet
|
Details | |
204-927-3
|
129-00-0
|
Germany
|
Bioaccumulation Persistence |
Concluded
|
SVHC
|
05-lip-2017
|
Details | |
603-051-2
|
125304-04-3
|
Germany
|
Bioaccumulation Other human toxicity Persistence |
Under development
|
No suggestion yet
|
Details | ||
201-581-5
|
85-01-8
|
Germany
|
Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
SVHC
|
05-lip-2017
|
Details | |
201-581-5
|
85-01-8
|
France
|
Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
SVHC
|
13-paź-2017
|
Details | |
206-801-3
|
375-95-1
|
Germany
|
Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
Restriction
|
07-mar-2017
|
Details | |